CXCL11 and colorectal carcinoma: Among total 19 individual up-regulated biomarkers belonging to at least one signature, ANXA3 (OS), IL8 (CXCL8) (OS), and CXCL11 (DFS) were associated with the preferred outcome of CRC patients.